跳至主要内容
临床试验/TCTR20191217002
TCTR20191217002招募中未知

The effect of soy milk on levothyroxine absorption

Faculty of Medicine Ramathibodi Hospital, Mahidol University0 个研究点目标入组 10 人开始时间: 2019年12月17日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
All

入选标准

  • 1. Healthy volunteers
  • 2. Aged 18-45 years
  • 3. Written informed consent by volunteer

排除标准

  • 1. Adults with recent acute illness, cardiovascular disease/abnormal electrocardiogram, renal insufficiency (serum creatinine >1.5 mg/dL), abnormal liver function (AST and/or ALT > 3 times of upper normal limit)
  • 2. Use of certain medications that interfere with levothyroxine absorption such as iron, calcium, proton pump inhibitor, sucralfate, aluminium hydroxide, cholestyramine; affect with levothyroxine metabolism such as phenytoin, carbamazepine, phenobarbital, rifampicin, tyrosine kinase inhibitor
  • 3. Use of certain medications that alter thyroid hormone levels such as amiodaraone, lithium, interfereon-alpha, alemtuzumab, glucocorticoid, somatostatin
  • 4. Use of certain medications that affect with thyroxine-binding globulin such as estrogen, raloxifene, tamoxifen, mitotane, fluorouracil, methadone, heroin, androgen, nicotinic acid
  • 5. Adults who had intestinal absorption problem or history of gastric/intestinal surgery
  • 6. Adults with allergy to soy and/or levothyroxine
  • 7. Pregnant women/lactating women
  • 8. Adults who has abnormal TSH concentrations
  • 9. Denied to participate in the study

研究者

相似试验